期刊文献+

慢性HBV感染患者抗原表位特异性CTL与ALT水平无关 被引量:2

ALT Level was Independent to Antigen-specific Cytotoxic T Lymphocytes in Patients with Chronic Hepatitis B
下载PDF
导出
摘要 【目的】通过定量分析慢性乙型肝炎患者体内乙型肝炎病毒(HBV)特异性的细胞毒性T淋巴细胞,探讨特异性细胞毒性T淋巴细胞水平与血清丙氨酸氨基转移酶水平和病毒复制状态的关系。【方法】从慢性乙型肝炎患者外周血分离外周血单个核细胞(PBMC),用HLA-A2限制的HBcAg抗原表位肽-五聚体复合体及CD8单克隆抗体染色后,用流式细胞仪检测HBV特异性的细胞毒性T淋巴细胞,同时检测患者的肝功能和定量分析HBVDNA。【结果】32例HLA-A2阳性的慢性乙型肝炎患者外周血均可检测到HBV特异性的细胞毒性T淋巴细胞,五聚体阳性细胞占CD8阳性细胞的比例为1.3%±1.1%,统计分析抗原表位特异性细胞毒性T淋巴细胞频率与丙氨酸氨基转移酶水平相关性不显著(r=0.163,P=0.163)。分组对比发现病毒载量低者(HBVDNA定量<105拷贝/mL)抗原表位特异性细胞毒性T淋巴细胞水平(1.96%±1.26%)高于病毒载量高者(0.82%±0.52%,P<0.05)。【结论】慢性乙型肝炎患者外周血中存在抗原表位特异性细胞毒性T淋巴细胞,抗原表位特异性细胞毒性T淋巴细胞可能与控制HBV的复制有关,但主要肝损害并非直接由抗原表位特异性细胞毒性T淋巴细胞引起。 [Objective] To detect HBV antigen specific cytotoxic T lymphocytes (CTL) and study their association with alanine aminotransferase (ALT) and viral replication in chronic hepatitis B patients. [Methods] The frequency of HBcAg -specific CTL cells in the peripheral blood mononuclear cells (PBMC) from 32 patients persistent infection with HBV were quantified by flow cytometry using HLA-A2 restricted HBV peptide pentamers complex(Pro5TM MHC Pentamers).[Results] The HBcAg-specific CTL cells were detected in all individuals with chronic HBV infection, the average of the frequency of HBcAg-specific CTL cells were 1.3%±1.1%. The frequency of HBcAg-specific CTL had no relationship with level of ALT (r=0.163 ,P=0.163). The patients with low virus load (HBV DNA 〈 10^5 copies/mL) had more HBV-specific CTL cells (1.96%±1.26%) than the patients with high virus load (0.82%±0.52%, P〈 0.05). [Conclusions] The patients with chronic HBV infection had HBcAg-specific CTL in peripheral blood. HBcAg-specific CTL may play an important role in inhibiting viral replication of the patients with chronic hepatitis B. But major liver cell damage was not directly caused by antigen-specific CTL.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2006年第4期401-404,413,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省科技计划项目(2005B31201004)
关键词 T淋巴细胞 细胞毒性 HLA抗原 肝炎 乙型 MHC-五聚体 T lymphocytes, cytotoxic HLA antigens hepatitis B MHC-pentamers
  • 相关文献

参考文献15

  • 1CHISARI F V,FERRARI C.Hepatitis B virus immunopathogenesis[J].Ann Rev Immunol,1995,13(1):29 -60.
  • 2MAINI M K,BONI C,LEE C K,et al.The role of virus-specific CD8 + cells in liver damage and viral control during persistent hepatitis B virus infection[J].J Exp Med,2000,191(8):1269-1280.
  • 3LIAW Y F.Hepatitis flare and hepatitis B e antigen seroconversion:implication in anti-hepatitis B virus therapy[J].J Gastroenterol Hepatol,2003,18(18):246-252.
  • 4SHIMADA N,YAMAMOTO K,KURODA M J,et al.HBcAg-specific CD8 T cells play an important role in virus suppression,and acute flare-up is associated with the expansion of activated memory T cells[J].J Clin Immunol,2003,23(3):223-232.
  • 5TSAI S L,SHEEN I S,CHIEN R N,et al.Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C:tetramer assay and therapeutic implications[J].J Biomed Sci,2003,10(1):120-135.
  • 6GANEM D,PRINCE A M.Hepatitis B virus infectionnatural history and clinical consequences[J].N Engl J Med,2004,350(11):1118-1129.
  • 7张晓红,马会慧,崇雨田,肖杰生,姚集鲁.慢性乙肝患者停用拉米夫定后出现肝功能衰竭的危险因素[J].中山大学学报(医学科学版),2005,26(3):329-332. 被引量:6
  • 8中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14012
  • 9WU Y Z,ZHANG J,CHEN S Y,et al.Frequencies of epitope-specific cytotoxic T lymphocytes in active chronic viral hepatitis B infection by using MHC class I peptide tetramers[J].Immunol Lett,2004,92(3):253-258.
  • 10范振平,王福生,徐东平,褚福亮,施明,周宇,张玲霞.乙型肝炎患者HBcAg特异性细胞毒性T细胞的检测及其与临床疾病状态的关系[J].中华医学杂志,2004,84(24):2073-2076. 被引量:18

二级参考文献35

  • 1WangB ChenH JiangX ZhangM WanT LiN ZhouX WuY YangF YuY WangX YangR CaoX.Identification of an HLA-A~* 0201-restricted CD8^+ T-cell epitope SSp-1 of SARS-CoV spike protein[J].第二军医大学学报,2004,25(9):969-969. 被引量:21
  • 2拉米夫定临床应用专家组 ,万谟彬.2004年拉米夫定临床应用专家共识[J].中华肝脏病杂志,2004,12(7):425-428. 被引量:257
  • 3周元平,彭文伟,姚集鲁,吕凌,李国辉,黄洁夫,彭宝刚,陈青.肝细胞癌与HCV、HBV感染关系的病例对照研究[J].中山医科大学学报,1994,15(1):45-49. 被引量:11
  • 4病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 5郭亚兵 喻新民 等.拉米夫定停药后慢性乙型肝炎病情加重3例报道[J].中华肝脏病杂志,2000,8(6):360-360.
  • 6Lim SG, Wai CT, Rajnakova A, et al. Fatal hepatitis B reactivation following discontinuation of nucleosideanalogues for chronic hepatitis B [J]. Gut, 2002, 51(4):597-9.
  • 7Bruno R, Sacchi P, Filice C, et al. Acute liver failure during lamivudine treatment in a hepatitis B cirrhotic patient[J]. Am J Gastroenterol, 2001, 96(1): 265.
  • 8Lee HC, Suh DJ. Lamivudine therapy for decompensated liver cirrhosis related to hepatitis B virus infection [J]. Intervirology, 2003,46(6): 388-93.
  • 9Honkoop P, de Man RA, Niesters HG, et al. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy[J]. Hepatology, 2000,32(3):635-9.
  • 10Dienstag JL, Schiff ER, Mitchell M,et al. Extended lamivudine retreatment for chronic hepatitis B:maintenance of viral suppression after discontinuation of therapy[J]. Hepatology, 1999,30(4): 1082-7.

共引文献14029

同被引文献24

  • 1范振平,王福生,徐东平,褚福亮,施明,周宇,张玲霞.乙型肝炎患者HBcAg特异性细胞毒性T细胞的检测及其与临床疾病状态的关系[J].中华医学杂志,2004,84(24):2073-2076. 被引量:18
  • 2李晓东,徐东平,成军,钟彦伟,刘妍,董菁,王琳,张玲霞.中国人群流行的乙型肝炎病毒特异性CTL表位特点分析[J].解放军医学杂志,2006,31(8):775-777. 被引量:12
  • 3沐小敏,谢志春.CpG ODN的体外免疫活性及其作为乙肝疫苗佐剂的研究新进展[J].热带医学杂志,2007,7(8):833-836. 被引量:1
  • 4Visvanathan K, Lewin SIR. Immunopathogenesis: role of innate and adaptive immune responses[J]. Semin Liver Dis, 2006, 26 (2) : 104- 115.
  • 5Hwang HY, Kim TG, Kim TY. Analysis of T cell receptor alpha- chain variable region (Va) usage and CDR3α of T cells infiltrated into lesions of psoriasis patients[J]. Mol Imrnunol, 2006, 43 (6) : 420-425.
  • 6Guidotti L G, Rochford R, Chung J, et al. Viral clearance without destruction of infected cells during acute HBV irfection[J]. Science, 1999, 284(5414) : 825-829.
  • 7Chung MK, Yoon H, Min SS, etal. Induction of cytotoxie T lymphocytes with peptides in vitro : identification of candidate T-cell ep tiopes in hepatitis B virus X antigen[J]. J Immunother, 1999, 22 (4) :279-287.
  • 8Maini MK, Boni C, Hee CK, et al. The role of virus-specific CD8^+ T cells in liver damage and viral control during persistent hepatitis B virus infection[J]. J Exp Med, 2000, 191(8) : 1269-1280.
  • 9Tang TJ, Kwekkeboom J, Laman JD, etal. The role of intrahepatic immune effector ceils in inflammatory liver injury and viral control during chronic hepatitis B irfeetion[J]. J Viral Hepat, 2003, 10(3): 159-167.
  • 10Hasegawa A, Moriya C, Liu H, et al. Analysis of TCR combinations used by simian immunodeficiency virus-specific CD8^+ T cells in rhesus monkeys: implications for CTL immunodominance[J]. J Immunol, 2007, 178(6): 3409-3417.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部